FBXO11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.711900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.105430E-01
Normal-vs-Stage2
5.877700E-02
Normal-vs-Stage3
5.919700E-02
Normal-vs-Stage4
4.500000E-01
Stage1-vs-Stage2
7.802000E-01
Stage1-vs-Stage3
8.841900E-02
Stage1-vs-Stage4
3.113200E-01
Stage2-vs-Stage3
2.565600E-01
Stage2-vs-Stage4
3.005000E-01
Stage3-vs-Stage4
5.937700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.392200E-02
Normal-vs-AfricanAmerican
2.403600E-01
Normal-vs-Asian
2.002000E-02
Caucasian-vs-AfricanAmerican
8.162800E-01
Caucasian-vs-Asian
3.605600E-02
AfricanAmerican-vs-Asian
1.481210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.455600E-02
Normal-vs-Female
6.050400E-02
Male-vs-Female
4.954200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.975400E-01
Normal-vs-Age(41-60Yrs)
1.402450E-01
Normal-vs-Age(61-80Yrs)
4.810100E-02
Normal-vs-Age(81-100Yrs)
2.097400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.276400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.563600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.806390E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.577900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.100600E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.036600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.076100E-02
Normal-vs-Daily Drinker
5.528100E-02
Normal-vs-Weekly Drinker
5.579900E-02
Normal-vs-Occasional Drinker
1.275350E-01
Normal-vs-Social Drinker
2.838400E-01
Non Drinker-vs-Daily Drinker
8.523800E-01
Non Drinker-vs-Weekly Drinker
7.967400E-01
Non Drinker-vs-Occasional Drinker
5.124100E-02
Non Drinker-vs-Social Drinker
1.205820E-01
Daily Drinker-vs-Weekly Drinker
7.039200E-01
Daily Drinker-vs-Occasional Drinker
1.052610E-01
Daily Drinker-vs-Social Drinker
2.047000E-01
Weekly Drinker-vs-Occasional Drinker
6.417700E-02
Weekly Drinker-vs-Social Drinker
1.572840E-01
Occasional Drinker-vs-Social Drinker
9.702600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.026500E-02
Normal-vs-Grade 2
6.375000E-04
Normal-vs-Grade 3
8.840300E-04
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.004000E-01
Grade 1-vs-Grade 3
1.755050E-01
Grade 1-vs-Grade 4
2.026500E-02
Grade 2-vs-Grade 3
4.798800E-01
Grade 2-vs-Grade 4
6.375000E-04
Grade 3-vs-Grade 4
8.840300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.200400E-02
Normal-vs-NonDiabetic
4.769800E-02
Diabetic-vs-NonDiabetic
5.387400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.754100E-02
Normal-vs-NoPancreatitis
5.696500E-02
Pancreatitis-vs-NoPancreatitis
5.679800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.564200E-02
Normal-vs-N1
6.242400E-02
N0-vs-N1
7.827200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.210100E-02
Normal-vs-TP53-NonMutant
8.854100E-02
TP53-Mutant-vs-TP53-NonMutant
7.341400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
